ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質(癌免疫療法用)

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
VE4-M4216
製品名称
ActiveMax Recombinant Mouse VEGF164 (HPLC-verified)
タンパク質名
VEGF164
Species
Mouse
HOST
HEK293
20ug: 42,000円
お問い合わせ
50ug: 84,000円
お問い合わせ

Overview

Synonyms RP1-261G23.1,MGC70609,MVCD1,VEGFA,VPF
Characteristics This protein carries no "tag". The protein has a calculated MW of 19.3 kDa. The protein migrates as 23-25 kDa under reducing (R) condition (SDS-PAGE) due to different glycosylation.
Endotoxin Level Less than 1.0 EU per μg by the LAL method.
Purity >95% as determined by SDS-PAGE.
Description Vascular endothelial growth factor A (VEGFA) is also known as Vascular permeability factor (VPF). VEGFA belongs to the PDGF/VEGF growth factor family. VEGFA is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. VEGFA is produced by a group of three major isoforms as a result of alternative splicing and if any three isoforms are produced (VEGFA120, VEGFA164, and VEGFA188) then this will not result in vessel defects and death of the full VEGFA knockout in mice.
Reference (1) Shin S.-Y., et al., 2005, Yonsei Med. J. 46:679-686.
(2) Breier G., et al., 1992, Development 114:521-532.
URL https://www.acrobiosystems.com/P799-Mouse-VEGF164-ProteinHEK293-expressedActiveMax.html

お問い合わせリスト(-)

お問い合わせフォーム